論文
2022年3月16日 09時52分 [総研 新保 30421]「The transcription factor unc-130/FOXD3/4 contributes to the biphasic calcium response required to optimize avoidance behavior.」
Scientific reports 12(1) 1907-1907 2022年2月3日
謝辞掲載に関するお願い
論文発表
「The transcription factor unc-130/FOXD3/4 contributes to the biphasic calcium response required to optimize avoidance behavior.」
Scientific reports 12(1) 1907-1907 2022年2月3日
論文
2022-03-16
[総研 新保 30421]
Sayaka Hori, Shohei Mitani
「The transcription factor unc-130/FOXD3/4 contributes to the biphasic calcium response required to optimize avoidance behavior.」
Scientific reports 12(1) 1907-1907 2022年2月3日
「The transcription factor unc-130/FOXD3/4 contributes to the biphasic calcium response required to optimize avoidance behavior.」
Scientific reports 12(1) 1907-1907 2022年2月3日
学会発表
学会発表
2017-12-26
[総研 早川 26419]
● Yuki Ichimura, Tomoaki Higuchi, Ikuko Masuda, Yasushi Kawaguchi, Hisashi Yamanaka.
2ccPA attenuates the fibrotic phenotype of dermal fibroblasts from patientswith systemic sclerosis and bleomycin-induced skin fibrosis.
第45回日本免疫学会・学術集会、沖縄県宜野湾市、2016/12
● Tomoaki Higuchi, Yasushi Kawaguchi, Kae Takagi, Akiko Tochimoto,Yuki Ichimura, Yasuhiro Katsumata, Hisae Ichida, Hidenaga Kawasumi, Hirokazu Nishina, Mari Tochihara, Akira Nishino, Shinya Hirahara, Rina Moriyama, Hisashi Yamanaka.
Apremilast Attenuates the Fibrogenic Phenotype of Dermal Fibroblasts from Patients with Systemic Sclerosis, Contributing to the Prevention of the Progression of Experimental Dermal Fibrosis.
ACR 2016, Washington DC. 2016/11
2ccPA attenuates the fibrotic phenotype of dermal fibroblasts from patientswith systemic sclerosis and bleomycin-induced skin fibrosis.
第45回日本免疫学会・学術集会、沖縄県宜野湾市、2016/12
● Tomoaki Higuchi, Yasushi Kawaguchi, Kae Takagi, Akiko Tochimoto,Yuki Ichimura, Yasuhiro Katsumata, Hisae Ichida, Hidenaga Kawasumi, Hirokazu Nishina, Mari Tochihara, Akira Nishino, Shinya Hirahara, Rina Moriyama, Hisashi Yamanaka.
Apremilast Attenuates the Fibrogenic Phenotype of Dermal Fibroblasts from Patients with Systemic Sclerosis, Contributing to the Prevention of the Progression of Experimental Dermal Fibrosis.
ACR 2016, Washington DC. 2016/11